Tumor necrosis factor-inhibitor treatment duration is associated with lower risk of hand osteoarthritis progression in patients with recent-onset rheumatoid arthritis after 10-year follow-up. (April 2018) - Loef, M.; Kroon, F.P.; Bergstra, S.A.; van der Pol, J.A.; Lems, W.F.; Kerstens, P.J.; Allaart, C.F.; Kloppenburg, M.